Non-Syndromic Rod-Dominant Inherited Retinal Diseases Clinical Trials in Sydney, New South Wales

A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)